{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:16:19Z","timestamp":1773303379418,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T00:00:00Z","timestamp":1236297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Prodynorphin (<jats:italic>PDYN<\/jats:italic>) binds to \u03ba\u2010opioid receptors and is known to regulate dopaminergic tone, making this system important for the reinforcing and rewarding properties of drugs of abuse such as opioids. The binding of dynorphins to \u03ba\u2010opioid receptors also produces aversive states that may affect the development of opioid dependence. Recent animal results have shown that<jats:italic>PDYN<\/jats:italic>knockout mice show decreased ethanol consumption; however, this finding was restricted to female mice. We were interested to analyse a possible gender specificity of dynorphin effects in humans and to this end three single\u2010nucleotide polymorphisms (SNPs) in<jats:italic>PDYN<\/jats:italic>were genotyped in a Chinese population of 484 opioid dependents and 374 controls. An interaction between sex and genotype was found in female opioid dependents. Chi\u2010squared tests for association revealed that the genotype distributions of SNPs rs1997794 (<jats:italic>P<\/jats:italic>\u2003=\u20030.019) and rs1022563 (<jats:italic>P<\/jats:italic>\u2003=\u20030.006) in the promoter and 3\u2032 region of<jats:italic>PDYN<\/jats:italic>, respectively, were found to be associated with opioid dependence. Therefore, SNPs in<jats:italic>PDYN<\/jats:italic>are significantly associated with the risk of developing opioid dependence; however, this effect may only be seen in females. These data suggest that<jats:italic>PDYN<\/jats:italic>polymorphisms should be studied in additional female opioid\u2010dependent populations with an emphasis on the promoter and 3\u2032 regions of the gene.<\/jats:p>","DOI":"10.1111\/j.1369-1600.2009.00151.x","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T12:05:05Z","timestamp":1236341105000},"page":"366-370","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["GENETIC STUDY: An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population"],"prefix":"10.1111","volume":"14","author":[{"given":"Toni\u2010Kim","family":"Clarke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunter","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,6,10]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1006\/smns.1997.0108"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1916"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bth457"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2006.12.002"},{"key":"e_1_2_6_7_1","unstructured":"DudbridgeF(2006)UNPHASED user guide. Technical Report 2006\/5."},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(02)00312-3"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1069424"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.687"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-3565(24)37950-9","article-title":"Dynorphin A1\u201313 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions","volume":"288","author":"Kreek MJ","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.11.973"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)00829-X"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041444-200512000-00013"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890120206"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1706"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.136.4.1589"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(93)90133-A"},{"key":"e_1_2_6_19_1","first-page":"398","article-title":"The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping","volume":"16","author":"Tobler AR","year":"2005","journal-title":"J Biomol Tech"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.0.CO;2-L"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.11.967"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(99)00021-2"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(82)90509-X"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2007.00069.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001882"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1996.15.1105"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.740472.x"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1369-1600.2009.00151.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1369-1600.2009.00151.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T02:05:10Z","timestamp":1738980310000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1369-1600.2009.00151.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,10]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1369-1600.2009.00151.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1369-1600.2009.00151.x","archive":["Portico"],"relation":{},"ISSN":["1355-6215","1369-1600"],"issn-type":[{"value":"1355-6215","type":"print"},{"value":"1369-1600","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,10]]},"assertion":[{"value":"2009-06-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}